WheelchairsNCT06566040
Wheelchair Provision Time for Hospital Inpatients
An observational study of Wheelchairs, run by Nova Scotia Health Authority at 1 site in Canada.
Trial summary
In a Pilot Study, the median Wheelchair Lead Time (from when a wheelchair was ordered by an Occupational Therapist for an inpatient in the Central Zone of Nova Scotia Health to when the wheelchair arrived at the destination facility) of 119 wheelchairs was 2.98 days, with median Wheelchair Assembly Time and Wheelchair… Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Wheelchairs
- What is being tested?
- Wheelchair
- Type of treatment
- Medical device
- How many people
- 119 participants
- Where
- 1 siteCanada
- Study dates
- 1 Oct 2024to Jun 2026
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Patients hospitalized in the Central Zone of Nova Scotia Health for whom a wheelchair was ordered using the WheelEase software.
Who may be able to join
- to have been an inpatient in a Central Zone hospital site during the 11-weekday study period in late January 2023
- , to have had a WheelEase order placed during the 11-weekday study period in late January 2023
- to have had a Wheelchair Delivery Time recorded
- to have been subsequently discharged from a Central Zone hospital site.
Who cannot join
- if the WheelEase order was cancelled before delivery.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Correlations Between Wheelchair Provision Time for Hospital Inpatients and Their Lengths of Stay and Costs of Hospitalization
In a Pilot Study, the median Wheelchair Lead Time (from when a wheelchair was ordered by an Occupational Therapist for an inpatient in the Central Zone of Nova Scotia Health to when the wheelchair arrived at the destination facility) of 119 wheelchairs was 2.98 days, with median Wheelchair Assembly Time and Wheelchair Delivery Time components of 0.98 and 1.00 days respectively. (For the over 3,000 inpatients/year for whom an order is placed, Wheelchair Delivery Time is not routinely recorded.) Reductions in Wheelchair Lead Time have the potential to speed patient mobilization (with benefits to the patient) and reduce both the patient's hospital Length of Stay and the patient-related Cost of Hospitalization. However, these potential benefits remain speculative. The objective of this project is to test the hypotheses that there are significant positive associations between Wheelchair Lead Time and both Length of Stay and the Cost of Hospitalization.
Read the detailed description
The wheelchair provision process within the Central Zone of Nova Scotia Health includes the ordering, assembly, and delivery of wheelchairs from where the inventory is stored at the Nova Scotia Rehabilitation and Arthritis Centre to inpatient units at 10 sites. At discharge from hospital, the wheelchair is typically returned, cleaned and placed back in inventory. The WheelEase software that tracks components of this process was developed locally in 2001, ownership of which has transferred to the Nova Scotia Health Assistive Technology Program. The software has been periodically refined. As an indication of the volume or orders, during the 6-month period from April 1 to September 30, 2021, there were 257-277 orders per month (~13/weekday) and the WheelEase database includes over 34,000 historical wheelchair orders. People who require wheelchairs after discharge need to rent or purchase them, a process that can take several months.
During the 2022-2023 Academic Year, the Wheelchair Research Team proposed and directed a Pilot Study by a group of four final-year Industrial Engineering students. The objective of the Capstone Project was to analyze Nova Scotia Health's wheelchair provision process for inpatients in the Central Zone and provide recommendations that might improve the quality of care provided and save costs. The students used a variety of methods to collect data including regularly checking loading docks and delivery spaces, tracker sheets, Global Positioning System trackers, interviews, contextual inquiry and shadowing of wheelchair technicians, a survey of Occupational Therapists (of whom there were 64 in the Central Zone), a discrete-event simulation to compare sequencing rules for the order in which the technicians build wheelchairs and a review of the existing WheelEase database.
Among other findings from the Pilot Study, during an 11-weekday period in late January 2023, the median Wheelchair Lead Time of 119 wheelchairs was 2.98 days, with median Wheelchair Assembly Time and Wheelchair Delivery Time components of 0.98 and 1.00 days respectively. Variations among sites and the day of the week that the order was placed were identified. The average 24-hour cost of a hospital bed in the Central Zone was $1,101 (range $557-1,313).
By comparison, in a quality-improvement project on 750 inpatients with spinal cord injury in a large American hospital, Taylor et al. reported that patients with cervical-level injury had the highest mean wait times (8.28 days) for powered wheelchairs and the second highest was for manual rigid-frame wheelchairs (6.29 days). Other studies have found that the early mobilization of patients can lead to reductions in medical complications, lengths of stay and costs.
In summary, reductions in the Wheelchair Lead Time could speed patient mobilization (with benefits to the patient) and reduce the patient's hospital Length of Stay and the patient-related Cost of Hospitalization. However, at this time, these potential benefits remain speculative. The objectives for this Project are to test the hypotheses that there are positive correlations between Wheelchair Lead Time and both Length of Stay and the Cost of Hospitalization.
METHODS
Sample size Of the 119 patients available from the Pilot Study, the investigators plan to study all who meet the inclusion/exclusion criteria.
Database extraction The investigators will use the Medical Record Number and WheelEase order number to link, extract and deanonymize the data we need from the STAR (or Discharge Abstract), WheelEase, Capstone Pilot Study and Finance Department databases into an Excel file. The following data elements will be recorded in a common dataset: Medical Record Number, WheelEase order number, Date of birth, Sex, Diagnosis accounting for admission, Discharge destination, Order Origin, Order Date and time, Order Wheelchair type, Assembly Date and time, Delivery Date and time, and Hospital case cost.
Statistical analyses From the date of birth and order date, the investigators will calculate the age (in years) when the order was placed. From the dates for the Order, Assembly and Delivery events, the investigators will determine the days of the week corresponding to those dates. From the three events, three periods will be calculated: Wheelchair Assembly Time (from when ordered to assembled), Wheelchair Delivery Time (from when assembled to delivered) and Wheelchair Lead Time (from when ordered to delivered). All data will be reported descriptively. Where appropriate, the normality of the quantitative data will be assessed to guide the use of parametric vs nonparametric statistics. To test the hypotheses, the investigators will use Pearson or Spearman correlation coefficients. Secondarily, multivariate regression will be carried out with both Length of Stay and Cost of Hospitalization as dependent measures and age, sex, diagnosis, day of week that the order was placed (excluding weekends and holidays), site and wheelchair type as independent measures. The alpha level will be defined as 0.05. SAS statistical software will be used.
Economic analysis Hospital case cost includes all Nova Scotia Health direct, indirect and total costs (e.g., bed, lab, imaging, food, allied health, but excluding physician costs, operating-room supplies and days less than 24 hours) typically available up to the end of the prior fiscal year (March 31). Although the literature suggests that there should be positive patient outcomes resulting from any reductions in Wheelchair Lead Time, the investigators will not have data on such outcomes. Therefore, the economic analysis will be conducted from the perspective of the benefits to society. In any healthcare system with financial constraints, any system benefits must be weighed against their costs.
- Conditions
- Wheelchairs
- Being tested
- Wheelchair
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
WheelchairDevice
Wheelchairs provided to hospital inpatients
What is being measured
The primary outcome is the main question the study is designed to answer.
Wheelchair Lead Time
Time from order placement to delivery to hospital site
Measured: Through initial study completion in 1 year
Secondary outcomes (2)
Length of stay
Duration of hospital admission
Measured: Through initial study completion in 1 year
Case cost
Cost of hospitalization
Measured: Through initial study completion in 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Aug 2024
- Study start1 Oct 2024
- Primary completion31 Dec 2025 (estimated)
- Study completionJun 2026 (estimated)
Why it stopped: Preliminary results analyzed, planning underway for next period of data collection
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for WheelchairsStudies of the same condition, open and under way.
- More trials run by Nova Scotia Health AuthorityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 119 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Nova Scotia Health Authority
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Ronald L Kirby, MD, Principal investigator, Dalhousie University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06566040
- Sponsor's protocol ID
- REB1030610
- Status last verified
- Aug 2024
- First submitted
- 21 Jun 2024
- Last updated
- 18 Feb 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 Feb 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Correlations Between Wheelchair Provision Time for Hospital Inpatients and Their Lengths of Stay and Costs of Hospitalization
- ClinicalTrials.gov ID
- NCT06566040
- Acronym / sponsor ID
- REB1030610
- Conditions
- Wheelchairs
- Study type
- Observational
- Recruitment status
- SuspendedReason stopped: Preliminary results analyzed, planning underway for next period of data collection
- Enrolment
- 119 participants (estimated)
- Lead sponsor
- Nova Scotia Health AuthorityUniversity, hospital or other
- Study start
- 1 Oct 2024 (actual)
- Primary completion
- 31 Dec 2025 (estimated)
- Study completion
- Jun 2026 (estimated)
- First posted
- 22 Aug 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In a Pilot Study, the median Wheelchair Lead Time (from when a wheelchair was ordered by an Occupational Therapist for an inpatient in the Central Zone of Nova Scotia Health to when the wheelchair arrived at the destination facility) of 119 wheelchairs was 2.98 days, with median Wheelchair Assembly Time and Wheelchair Delivery Time components of 0.98 and 1.00 days respectively. (For the over 3,000 inpatients/year for whom an order is placed, Wheelchair Delivery Time is not routinely recorded.) Reductions in Wheelchair Lead Time have the potential to speed patient mobilization (with benefits to the patient) and reduce both the patient's hospital Length of Stay and the patient-related Cost of Hospitalization. However, these potential benefits remain speculative. The objective of this project is to test the hypotheses that there are significant positive associations between Wheelchair Lead Time and both Length of Stay and the Cost of Hospitalization.
Detailed description
The wheelchair provision process within the Central Zone of Nova Scotia Health includes the ordering, assembly, and delivery of wheelchairs from where the inventory is stored at the Nova Scotia Rehabilitation and Arthritis Centre to inpatient units at 10 sites. At discharge from hospital, the wheelchair is typically returned, cleaned and placed back in inventory. The WheelEase software that tracks components of this process was developed locally in 2001, ownership of which has transferred to the Nova Scotia Health Assistive Technology Program. The software has been periodically refined. As an indication of the volume or orders, during the 6-month period from April 1 to September 30, 2021, there were 257-277 orders per month (~13/weekday) and the WheelEase database includes over 34,000 historical wheelchair orders. People who require wheelchairs after discharge need to rent or purchase them, a process that can take several months.
During the 2022-2023 Academic Year, the Wheelchair Research Team proposed and directed a Pilot Study by a group of four final-year Industrial Engineering students. The objective of the Capstone Project was to analyze Nova Scotia Health's wheelchair provision process for inpatients in the Central Zone and provide recommendations that might improve the quality of care provided and save costs. The students used a variety of methods to collect data including regularly checking loading docks and delivery spaces, tracker sheets, Global Positioning System trackers, interviews, contextual inquiry and shadowing of wheelchair technicians, a survey of Occupational Therapists (of whom there were 64 in the Central Zone), a discrete-event simulation to compare sequencing rules for the order in which the technicians build wheelchairs and a review of the existing WheelEase database.
Among other findings from the Pilot Study, during an 11-weekday period in late January 2023, the median Wheelchair Lead Time of 119 wheelchairs was 2.98 days, with median Wheelchair Assembly Time and Wheelchair Delivery Time components of 0.98 and 1.00 days respectively. Variations among sites and the day of the week that the order was placed were identified. The average 24-hour cost of a hospital bed in the Central Zone was $1,101 (range $557-1,313).
By comparison, in a quality-improvement project on 750 inpatients with spinal cord injury in a large American hospital, Taylor et al. reported that patients with cervical-level injury had the highest mean wait times (8.28 days) for powered wheelchairs and the second highest was for manual rigid-frame wheelchairs (6.29 days). Other studies have found that the early mobilization of patients can lead to reductions in medical complications, lengths of stay and costs.
In summary, reductions in the Wheelchair Lead Time could speed patient mobilization (with benefits to the patient) and reduce the patient's hospital Length of Stay and the patient-related Cost of Hospitalization. However, at this time, these potential benefits remain speculative. The objectives for this Project are to test the hypotheses that there are positive correlations between Wheelchair Lead Time and both Length of Stay and the Cost of Hospitalization.
METHODS
Sample size Of the 119 patients available from the Pilot Study, the investigators plan to study all who meet the inclusion/exclusion criteria.
Database extraction The investigators will use the Medical Record Number and WheelEase order number to link, extract and deanonymize the data we need from the STAR (or Discharge Abstract), WheelEase, Capstone Pilot Study and Finance Department databases into an Excel file. The following data elements will be recorded in a common dataset: Medical Record Number, WheelEase order number, Date of birth, Sex, Diagnosis accounting for admission, Discharge destination, Order Origin, Order Date and time, Order Wheelchair type, Assembly Date and time, Delivery Date and time, and Hospital case cost.
Statistical analyses From the date of birth and order date, the investigators will calculate the age (in years) when the order was placed. From the dates for the Order, Assembly and Delivery events, the investigators will determine the days of the week corresponding to those dates. From the three events, three periods will be calculated: Wheelchair Assembly Time (from when ordered to assembled), Wheelchair Delivery Time (from when assembled to delivered) and Wheelchair Lead Time (from when ordered to delivered). All data will be reported descriptively. Where appropriate, the normality of the quantitative data will be assessed to guide the use of parametric vs nonparametric statistics. To test the hypotheses, the investigators will use Pearson or Spearman correlation coefficients. Secondarily, multivariate regression will be carried out with both Length of Stay and Cost of Hospitalization as dependent measures and age, sex, diagnosis, day of week that the order was placed (excluding weekends and holidays), site and wheelchair type as independent measures. The alpha level will be defined as 0.05. SAS statistical software will be used.
Economic analysis Hospital case cost includes all Nova Scotia Health direct, indirect and total costs (e.g., bed, lab, imaging, food, allied health, but excluding physician costs, operating-room supplies and days less than 24 hours) typically available up to the end of the prior fiscal year (March 31). Although the literature suggests that there should be positive patient outcomes resulting from any reductions in Wheelchair Lead Time, the investigators will not have data on such outcomes. Therefore, the economic analysis will be conducted from the perspective of the benefits to society. In any healthcare system with financial constraints, any system benefits must be weighed against their costs.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Patients hospitalized in the Central Zone of Nova Scotia Health for whom a wheelchair was ordered using the WheelEase software.
Key inclusion criteria (4 listed)
- to have been an inpatient in a Central Zone hospital site during the 11-weekday study period in late January 2023
- , to have had a WheelEase order placed during the 11-weekday study period in late January 2023
- to have had a Wheelchair Delivery Time recorded
- to have been subsequently discharged from a Central Zone hospital site.
Key exclusion criteria (1 listed)
- if the WheelEase order was cancelled before delivery.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| WheelchairWheelchairs provided to hospital inpatients | Device | – |
Primary outcome
Wheelchair Lead Time
Time frame: Through initial study completion in 1 year
Time from order placement to delivery to hospital site
2 secondary outcomes
Length of stay
Time frame: Through initial study completion in 1 year
Case cost
Time frame: Through initial study completion in 1 year
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Feb 2025.
- Individual participant dataSharing planned: No
Related trials for Wheelchairs
Active, not recruitingObservational study
Natural History of Shoulder Pathology in Manual Wheelchair Users
Paraplegia, Spinal Cord Injuries
Recruiting
Comparison Between Objective Biomechanical Cost and Perceived Physical Demand in Manual Wheelchair Users During Propulsion Tasks
Manual Wheelchair Use, Spinal Cord Injury
Not yet recruiting
Efficacy of Seated Physical Activity INtervention(SPIN) for Wheelchair Users With Multiple Sclerosis
Multiple Sclerosis
Not yet recruiting
Personal Exoskeleton or Manual Wheelchair: a Comparison of Performance and Satisfaction in Activities of Daily Living Among People With Spinal Cord Injuries, Using the SCED Methodology.
Paraplegia, Spinal Cord Injury
Not yet recruiting
User Evaluation of Advanced Personalized Modular Pressure Relief Seating Cushion Systems
Mobility Impairment
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ronald L Kirby, MD principal investigator
Dalhousie University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Wheelchairs, run by Nova Scotia Health Authority at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: paused, as of the sponsor's last update on 18 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Wheelchair Lead Time (time frame: Through initial study completion in 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Feb 2025.